• Considerations for the use of herpes zoster vaccines Cite CITE Title : Considerations for the use of herpes zoster vaccines Personal Author(s) : Dooling, Kathleen L. Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2017 June 21-22 : Atlanta, GA) Published Date : 7/17/2017 Series : ACIP meeting Herpes Zoster Vaccine URL : https://stacks.cdc.gov/view/cdc/58920 File Format: Copy Export RIS [PDF - 1.62 MB] Personal Author: Dooling, Kathleen L. 7/17/2017 | ACIP meeting Herpes Zoster Vaccine Description: Presentations June 2017 Day 1Publication date from document properties.zoster-05-dooling.pdf File Type: [PDF - 1.62 MB] File Type: [PDF - 1.62 MB] Immunogenicity and safety of Shingrix in adults previously vaccinated with a live-attenuated herpes zoster vaccine (zoster-048 study) Cite CITE Title : Immunogenicity and safety of Shingrix in adults previously vaccinated with a live-attenuated herpes zoster vaccine (zoster-048 study) Personal Author(s) : Colindres, Romulo Corporate Authors(s) : GlaxoSmithKline. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2017 June 21-22 : Atlanta, GA) Published Date : 7/14/2017 Series : ACIP meeting Herpes Zoster Vaccine URL : https://stacks.cdc.gov/view/cdc/58918 File Format: Copy Export RIS [PDF - 282.22 KB] Personal Author: Colindres, Romulo 7/14/2017 | ACIP meeting Herpes Zoster Vaccine Description: Presentations June 2017 Day 1Agenda lists presentation as: Herpes Zoster vaccine revaccination dataPublication date from document properties.zoster-03... File Type: [PDF - 282.22 KB] File Type: [PDF - 282.22 KB]

More +